Intra-arterial substance P mediated vasodilatation in the human forearm: Pharmacology, reproducibility and tolerability

被引:35
作者
Newby, DE
Sciberras, DG
Mendel, CM
Gertz, BJ
Boon, NA
Webb, DJ
机构
[1] UNIV EDINBURGH, WESTERN GEN HOSP, RES CTR, EDINBURGH, MIDLOTHIAN, SCOTLAND
[2] MERCK RES LABS, CLIN PHARMACOL EUROPE, HARLOW, ESSEX, ENGLAND
[3] MERCK RES LABS, CLIN PHARMACOL EUROPE, RAHWAY, NJ USA
关键词
substance P; vasodilatation; forearm plethysmography; pharmacodynamics; reproducibility; tolerability;
D O I
10.1046/j.1365-2125.1997.00583.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The current studies were designed to characterize the pharmacology, reproducibility and tolerability of the vasodilator response to intra-arterial substance P infusion in the forearm of healthy man. Methods On different occasions, eight healthy male volunteers received brachial artery infusions of substance P at doubling doses ranging from 0.5 to 128 pmol min(-1). Blood flow was measured in both arms using venous occlusion plethysmography. Results Substance P induced dose-dependent vasodilatation in the human forearm which had a log-linear relationship to dose. At doses of 1-8 pmol min(-1), mean responses were highly reproducible both within and between days. There were no differences between responses to discontinuous doses and continuous doses of substance P. Substance P was generally well tolerated at doses of less than or equal to 64 pmol min(-1) with no significant alteration in arterial blood pressure or heart rate. Skin oedema in the infused forearm and systemic vasodilatation, manifested by facial flushing and non-infused forearm vasodilatation, occurred at doses of greater than or equal to 16 pmol min(-1). Conclusions Forearm vasodilatation to substance P represents a reproducible and useful model in the assessment of peripheral endothelial cell NK1 receptor function.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 29 条
[1]  
ARONIN N, 1986, ANNU REV PHYSIOL, V48, P537
[2]   MODULATION OF NEUROGENIC INFLAMMATION - NOVEL APPROACHES TO INFLAMMATORY DISEASE [J].
BARNES, PJ ;
BELVISI, MG ;
ROGERS, DF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (05) :185-189
[3]   RECENT DEVELOPMENTS IN TACHYKININ NK1 RECEPTOR ANTAGONISTS - PROSPECTS FOR THE TREATMENT OF MIGRAINE HEADACHE [J].
BEATTIE, DT ;
CONNOR, HE ;
HAGAN, RM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (07) :871-877
[4]   MEASURING FOREARM BLOOD-FLOW AND INTERPRETING THE RESPONSES TO DRUGS AND MEDIATORS [J].
BENJAMIN, N ;
CALVER, A ;
COLLIER, J ;
ROBINSON, B ;
VALLANCE, P ;
WEBB, D .
HYPERTENSION, 1995, 25 (05) :918-923
[5]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]   SUBSTANCE-P PROVOKES CUTANEOUS ERYTHEMA AND EDEMA THROUGH A HISTAMINE-INDEPENDENT PATHWAY [J].
CAPPUGI, P ;
TSAMPAU, D ;
LOTTI, T .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (03) :206-209
[7]   IMPAIRED ENDOTHELIUM-DEPENDENT VASCULAR RELAXATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA EXTENDS BEYOND THE MUSCARINIC RECEPTOR [J].
CASINO, PR ;
KILCOYNE, CM ;
CANNON, RO ;
QUYYUMI, AA ;
PANZA, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (01) :40-44
[8]   INTRAVENOUSLY INFUSED SUBSTANCE-P ENHANCES BASAL AND GROWTH-HORMONE (GH) RELEASING HORMONE-STIMULATED GH SECRETION IN NORMAL MEN [J].
COIRO, V ;
VOLPI, R ;
CAPRETTI, L ;
SPERONI, G ;
BOCCHI, R ;
CAFFARRI, G ;
COLLA, R ;
ROSSI, G ;
CHIODERA, P .
PEPTIDES, 1992, 13 (04) :843-846
[9]   STIMULATION OF ACTH CORTISOL BY INTRAVENOUSLY INFUSED SUBSTANCE-P IN NORMAL MEN - INHIBITION BY SODIUM VALPROATE [J].
COIRO, V ;
CAPRETTI, L ;
VOLPI, R ;
DAVOLI, C ;
MARCATO, A ;
CAVAZZINI, U ;
CAFFARRI, G ;
ROSSI, G ;
CHIODERA, P .
NEUROENDOCRINOLOGY, 1992, 56 (04) :459-463
[10]   SUBSTANCE-P DILATES EPICARDIAL CORONARY-ARTERIES AND INCREASES CORONARY BLOOD-FLOW IN HUMANS [J].
CROSSMAN, DC ;
LARKIN, SW ;
FULLER, RW ;
DAVIES, GJ ;
MASERI, A .
CIRCULATION, 1989, 80 (03) :475-484